- Home
- CDNA vs QCRH Comparison
CDNA vs QCRH Comparison
Compare CDNA & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- QCRH
- Stock Information
- Founded
- CDNA 1998
- QCRH 1993
- Country
- CDNA United States
- QCRH United States
- Employees
- CDNA N/A
- QCRH N/A
- Industry
- CDNA Medical Specialities
- QCRH Major Banks
- Sector
- CDNA Health Care
- QCRH Finance
- Exchange
- CDNA Nasdaq
- QCRH Nasdaq
- Market Cap
- CDNA 1.0B
- QCRH 1.1B
- IPO Year
- CDNA 2014
- QCRH 1993
- Fundamental
- Price
- CDNA $19.14
- QCRH $67.61
- Analyst Decision
- CDNA Buy
- QCRH Buy
- Analyst Count
- CDNA 6
- QCRH 3
- Target Price
- CDNA $30.33
- QCRH $86.67
- AVG Volume (30 Days)
- CDNA 989.3K
- QCRH 87.3K
- Earning Date
- CDNA 07-30-2025
- QCRH 07-23-2025
- Dividend Yield
- CDNA N/A
- QCRH 0.35%
- EPS Growth
- CDNA N/A
- QCRH N/A
- EPS
- CDNA 1.07
- QCRH 6.65
- Revenue
- CDNA $346,421,000.00
- QCRH $324,275,000.00
- Revenue This Year
- CDNA $13.31
- QCRH N/A
- Revenue Next Year
- CDNA $15.46
- QCRH $7.10
- P/E Ratio
- CDNA $17.90
- QCRH $10.22
- Revenue Growth
- CDNA 25.92
- QCRH N/A
- 52 Week Low
- CDNA $14.09
- QCRH $57.43
- 52 Week High
- CDNA $34.84
- QCRH $96.08
- Technical
- Relative Strength Index (RSI)
- CDNA 54.80
- QCRH 55.36
- Support Level
- CDNA $18.64
- QCRH $63.68
- Resistance Level
- CDNA $19.84
- QCRH $68.56
- Average True Range (ATR)
- CDNA 0.74
- QCRH 1.48
- MACD
- CDNA -0.05
- QCRH 0.34
- Stochastic Oscillator
- CDNA 39.61
- QCRH 79.77
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.